작성일 : 17-04-06 10:51
[2017] 4월 7일 발표 논문입니다.
 글쓴이 : 종찬
조회 : 1,784  
   https://www.ncbi.nlm.nih.gov/pubmed/?term=miR-132+loss+de-represses+IT… [701]
EMBO Mol Med. 2016 Sep 1;8(9):1005-18. doi: 10.15252/emmm.201606520. Print 2016 Sep.
copy 
miR-132 loss de-represses ITPKB and aggravates amyloid and TAU pathology in Alzheimer's brain.

Salta E  1, Sierksma A  1, Vanden Eynden E  1, De Strooper B  2.
Author information
Abstract
microRNA-132 (miR-132) is involved in prosurvival, anti-inflammatory and memory-promoting functions in the nervous system and has been found consistently downregulated in Alzheimer's disease (AD). Whether and how miR-132 deficiency impacts AD pathology remains, however, unaddressed. We show here that miR-132 loss exacerbates both amyloid and TAU pathology via inositol 1,4,5-trisphosphate 3-kinase B (ITPKB) upregulation in an AD mouse model. This leads to increased ERK1/2 and BACE1 activity and elevated TAU phosphorylation. We confirm downregulation of miR-132 and upregulation of ITPKB in three distinct human AD patient cohorts, indicating the pathological relevance of this pathway in AD.